SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-20-000298
Filing Date
2020-01-06
Accepted
2020-01-06 16:29:24
Documents
2
Period of Report
2020-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 6847
2 ex24matsuda.txt EX-24 4468
  Complete submission text file 0001179110-20-000298.txt   12920
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121
Business Address 8587948889
Matsuda Masaru (Reporting) CIK: 0001798679 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32335 | Film No.: 20510105